Can bisphosphonate help in osteolytic metastases?;Konnen biphosphonate bei osteolytischen metastasen helfen?

HNO

Volumn 45, Issue 6, 1997, Pages 419-420

  Werner, J A ^a  

^a UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID;

BONE DESTRUCTION; BONE METASTASIS; DRUG EFFICACY; HUMAN; OSTEOCLAST; OSTEOLYSIS; SHORT SURVEY; ARTICLE; BONE DENSITY; BONE TUMOR; DRUG EFFECT; METASTASIS;

BONE DENSITY; BONE NEOPLASMS; DIPHOSPHONATES; HUMANS; OSTEOCLASTS; OSTEOLYSIS;

EID: 0031156440     PISSN: 00176192     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001060050116     Document Type: Short Survey

References (5)

1. Sins ES (1997) Breast cancer and osteolytic metastases: Can biphosphonates help? Nature Med 3:151-152
2. Fleisch H, Russell RGG (1970) Pyrophosphate and polyphosphate in Encyclopedia of Pharmacology and Therapeutics. Section 51. Pharmacology of the Endocrine System and Related Drugs. Pergamon, Oxford. 61-100
3. Watts NB, Harris ST, Genant HK, Wasnick RD, Miller PD, Jackson RD, Licata AA, Ross Woodson GC (1990) Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. N Engl J Med 323:73-79
4. Kanis JA (1997) Pathophysiology and treatment of Paget's Disease of Bone. Dunitz, London, 159-216
5. Hortobagyi GN, Theriault RL, Porter L, Blayney D, Lipton A, Sinoff C, Wheeler H, Knight RD, Heffarnan M, Reitsma DJ (1996) Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. N Engl J Med 335:1785-1791